Actively Recruiting

Age: 55Years - 75Years
All Genders
Healthy Volunteers
NCT04850053

Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis

Led by Capital Medical University · Updated on 2026-03-23

1500

Participants Needed

1

Research Sites

331 weeks

Total Duration

On this page

Sponsors

C

Capital Medical University

Lead Sponsor

S

Shandong Provincial Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The study will investigate the biomarkers of Aβ and Tau seeds in plasma detected by Alzheimer's disease (AD) related seeds quantitative detector (AD-seeds-detector), and their sensitivity and specificity in diagnosing AD, compared with those from age-matched cognitively normal controls, and those with other types of dementia. To perform a high throughput analysis of the amount of Aβ and Tau seeds, the investigators have developed an AD-seeds-detector, in which a fluorescence microplate reader was combined with an oscillating mixer or water-bath-type ultrasonicator.

CONDITIONS

Official Title

Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis

Who Can Participate

Age: 55Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 55 to 75 years
  • Written informed consent obtained from participant or legal guardian before any study procedures
  • Diagnosis of Alzheimer's Disease made using National Institute on Aging and Alzheimer's Association criteria
  • Diagnosis of non-Alzheimer's dementia made using appropriate criteria for each type (e.g., DLB, bvFTD, semantic variant FTD, PDD, VaD, CBD, CJD)
  • Normal cognition confirmed by MMSE, CDR, or other cognitive function tests
Not Eligible

You will not qualify if you...

  • Presence of other medical or psychiatric illnesses
  • Lack of an informant to provide information
  • Refusal to complete cognitive testing or provide biospecimens

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Xuanwu Hospital of Capital Medical University

Beijing, Beijing Municipality, China, 100053

Actively Recruiting

Loading map...

Research Team

J

Jianping Jia, Doctor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis | DecenTrialz